Pfizer Stops Enrollment in COVID-19 Pill Trial After Latest Results


Authors: Mimi Nguyen Ly June 16, 2022 The Epoch Times Paxlovid, a Pfizer COVID-19 pill, is seen manufactured in Ascoli, Italy, in this undated photo obtained by Reuters on Nov. 16, 2021. (Pfizer/Handout via Reuters) Pfizer has announced it will stop enrollment in a clinical trial for Paxlovid—its COVID-19 antiviral pill—for standard-risk COVID-19 patients after the latest results suggested […]

40-Year-Old British Columbia Man Diagnosed with Guillain-Barré Syndrome Is Awarded Compensation for Vaccine Injury (VIDEO)


Authors: Jim Hoft Published June 16, 2022  The Gateway Pundit A 40-year-old father from British Columbia was one of the first people in Canada to be compensated after suffering an adverse reaction connected to the COVID-19 vaccine. Ross Wightman, a former pilot and realtor was diagnosed with Guillain-Barré Syndrome (GBS), which is a rare disorder in […]

Mask mandate and use efficacy in state-level COVID-19 containment


Authors: Damian D. Guerra, Daniel J. Guerra doi: https://doi.org/10.1101/2021.05.18.21257385 Abstract Background Containment of the COVID-19 pandemic requires evidence-based strategies to reduce transmission. Because COVID-19 can spread via respired droplets, many states have mandated mask use in public settings. Randomized control trials have not clearly demonstrated mask efficacy against respiratory viruses, and observational studies conflict on whether mask use predicts lower […]

Self-reported outcomes, choices and discrimination among a global COVID-19 unvaccinated cohort


Authors: Robert Verkerk PhD1, Christof Plothe DO2, Naseeba Kathrada MBChB3 andKatarina Lindley DO4, Science Unit, Alliance for Natural Health International, 78 Dorking Road, Chilworth, Surrey, GU4 8NS, United Kingdom, Praxis für Biophysikalische Osteopathie, Am Wegweiser Alzey, Germany, Dr Kats, 86 Jan Hofmeyer Road, Dawncrest, Westville, 3629, South Africa, Lindley Medical, 2100 FM 1189, Brock, Texas […]

Severe COVID ‘Rare’ in People Who Didn’t Get Vaccine, Survey Reveals


A survey of 300,000 people who didn’t get the COVID-19 vaccine revealed the unvaccinated didn’t place a disproportionate burden on health systems — in fact, they experienced very low rates of hospitalization and severe COVID-19. Authors: Alliance for Natural Health International 06/09/22 There have been very few studies looking at how those who’ve elected to […]

CDC Says Moderna’s Covid-19 Vaccine Poses Greater Heart Inflammation Risk Than Pfizer


Authors: im Hoft Published June 14, 2022  Gateway Pundit Moderna’s COVID-19 vaccine may have a higher risk of heart inflammation than the Pfizer shot based on recent data, the U.S. Centers for Disease Control and Prevention said on Tuesday. On Tuesday, the U.S. Food and Drug Administration met with its Vaccines and Related Biological Products Advisory […]

24 Questions to Ask Your Doctor About the COVID-19 Vaccine


Experts address vaccination and children, safety, side effects, boosters, variants and long COVID. Authors:  Lisa Esposito The COVID-19 vaccine has been publicly available in the U.S. since December 2020. Since then, vaccination has eased the pandemic by preventing infections, reducing severe disease and saving lives. More is known about vaccine effectiveness, safety and side effects, which tend […]

What’s Graphene Oxide?


Is a toxic material hiding inside the COVID vaccines causing blood clots? Authors: Emerald Robinson Jun 13, 2022 As more and more people around the world share their stories of COVID vaccine injuries, the inevitable question becomes: what’s really in the experimental shots? This is not an academic question. In fact, it’s going to be […]

One Size Doesn’t Fit All: COVID-19 Vaccines and Immunocompromised Patients


Authors: Stephanie Desmon  Public Health On Call  Johns Hopkins Center for Communication Programs HOW CAN WE PROTECT THOSE WHO ARE IMMUNOCOMPROMISED? We’re doing two things. First, we’re working on the vaccine aspect. We got NIH funding to run a clinical trial of people who thus far have failed to reach a reasonable antibody level with whatever […]